These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18805842)

  • 21. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and patterns of cognitive impairment in sporadic ALS.
    Ringholz GM; Appel SH; Bradshaw M; Cooke NA; Mosnik DM; Schulz PE
    Neurology; 2005 Aug; 65(4):586-90. PubMed ID: 16116120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological investigations of multiple sclerosis: a clinical perspective.
    O'Connor MG
    Clin Neurosci; 1994; 2(3-4):225-8. PubMed ID: 7749892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature.
    O'Brien AR; Chiaravalloti N; Goverover Y; Deluca J
    Arch Phys Med Rehabil; 2008 Apr; 89(4):761-9. PubMed ID: 18374010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment in hemodialysis patients is common.
    Murray AM; Tupper DE; Knopman DS; Gilbertson DT; Pederson SL; Li S; Smith GE; Hochhalter AK; Collins AJ; Kane RL
    Neurology; 2006 Jul; 67(2):216-23. PubMed ID: 16864811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive dysfunction and multiple sclerosis: developing a rationale for considering the efficacy of exercise training.
    Motl RW; Sandroff BM; Benedict RH
    Mult Scler; 2011 Sep; 17(9):1034-40. PubMed ID: 21685231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How should DSM-V criteria for schizophrenia include cognitive impairment?
    Keefe RS; Fenton WS
    Schizophr Bull; 2007 Jul; 33(4):912-20. PubMed ID: 17567627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.
    Porcel J; Montalban X
    J Neurol Sci; 2006 Jun; 245(1-2):177-81. PubMed ID: 16674980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive functioning in multiple sclerosis.
    Julian LJ
    Neurol Clin; 2011 May; 29(2):507-25. PubMed ID: 21439456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive function in chronic kidney disease.
    Madero M; Gul A; Sarnak MJ
    Semin Dial; 2008; 21(1):29-37. PubMed ID: 18251955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Memory decline evolves independently of disease activity in MS.
    Duque B; Sepulcre J; Bejarano B; Samaranch L; Pastor P; Villoslada P
    Mult Scler; 2008 Aug; 14(7):947-53. PubMed ID: 18573817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE epsilon4 is associated with impaired verbal learning in patients with MS.
    Koutsis G; Panas M; Giogkaraki E; Potagas C; Karadima G; Sfagos C; Vassilopoulos D
    Neurology; 2007 Feb; 68(8):546-9. PubMed ID: 17310023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns.
    Tiemann L; Penner IK; Haupts M; Schlegel U; Calabrese P
    Mult Scler; 2009 Oct; 15(10):1164-74. PubMed ID: 19667010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinsonian signs in subjects with mild cognitive impairment.
    Boyle PA; Wilson RS; Aggarwal NT; Arvanitakis Z; Kelly J; Bienias JL; Bennett DA
    Neurology; 2005 Dec; 65(12):1901-6. PubMed ID: 16380610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis.
    Rocca MA; Amato MP; De Stefano N; Enzinger C; Geurts JJ; Penner IK; Rovira A; Sumowski JF; Valsasina P; Filippi M;
    Lancet Neurol; 2015 Mar; 14(3):302-17. PubMed ID: 25662900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptomatic management in multiple sclerosis.
    Samkoff LM; Goodman AD
    Neurol Clin; 2011 May; 29(2):449-63. PubMed ID: 21439453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.
    Bensa C; Bodiguel E; Brassat D; Laplaud D; Magy L; Ouallet JC; Zephir H; De Seze J; Blanc F;
    Rev Neurol (Paris); 2012 Nov; 168(11):785-94. PubMed ID: 22658753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cognitive impairment in multiple sclerosis].
    Krupińska-Dulembal A; Paradowskil B; Chojdak-Lukasiewicz J; Bladowska J
    Wiad Lek; 2014; 67(4):505-11. PubMed ID: 26030957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.